skip to navigation skip to content
Search

Two teams from Cambridge University will be able to accelerate their projects after winning a prestigious international competition to commercialise innovative breast cancer research. One of the winning teams, lead by Alice MacNeil, a former Research Assistant at Cambridge Judge Business School and now at Accenture, introduced a project for developing virus-like particles as a versatile delivery method for cancer therapeutics.

Read the full article [bulletin.sciencebusiness.net]